EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
    3.5.3.1 | Neoplasms |
17467 |
Some new approaches to potential test systems for drugs against prostatic cancer. |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 3.5.3.1 | Prostatic Neoplasms |
17467 |
Some new approaches to potential test systems for drugs against prostatic cancer. |
causal interaction
diagnostic usage
unassigned |
1
3
0 |
| 3.5.3.1 | Carcinoma, Hepatocellular |
22474 |
Establishment of a clonal strain of hepatoma cells derived from Morris hepatoma 8999. |
ongoing research
unassigned |
1
0 |
| 3.5.3.1 | Liver Diseases |
35582 |
The effect of thioacetamide on urea cycle enzymes of rat liver. |
unassigned |
0 |
| 3.5.3.1 | Digestive System Diseases |
41466 |
Use of plasma arginase and gamma-glutamyl transpeptidase as specific indicators of heptocellular or hepatobiliary disease in the dog. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
2
1
0 |
| 3.5.3.1 | Neoplasms |
163221 |
Characterization of a Wilms' tumor model. |
ongoing research
unassigned |
1
0 |
| 3.5.3.1 | arginase deficiency |
164740 |
Unsuccessful trial of gene replacement in arginase deficiency. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.5.3.1 | Hyperargininemia |
164740 |
Unsuccessful trial of gene replacement in arginase deficiency. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.5.3.1 | Papilloma |
164740 |
Unsuccessful trial of gene replacement in arginase deficiency. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 3.5.3.1 | Carcinoma, Hepatocellular |
170626 |
Growth inhibitory and arginase activities in liver and hepatoma extracts. |
ongoing research
unassigned |
3
0 |
